Literature DB >> 24461110

Only just the beginning of the end of hepatitis C.

.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24461110     DOI： 10.1016/S0140-6736(14)60087-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Aylur K Srikrishnan; Suniti Solomon; Allison M McFall; Oliver Laeyendecker; David D Celentano; Syed H Iqbal; Santhanam Anand; Canjeevaram K Vasudevan; Shanmugam Saravanan; Gregory M Lucas; Muniratnam S Kumar; Mark S Sulkowski; Thomas C Quinn
Journal:  Lancet Infect Dis       Date:  2014-12-03       Impact factor: 25.071

Review 2.  IFN-λ4: the paradoxical new member of the interferon lambda family.

Authors:  Thomas R O'Brien; Ludmila Prokunina-Olsson; Raymond P Donnelly
Journal:  J Interferon Cytokine Res       Date:  2014-04-30       Impact factor: 2.607

3.  Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.

Authors:  Graham R Foster; Carmine Coppola; Moutaz Derbala; Peter Ferenci; Alessandra Orlandini; K Rajender Reddy; Ludovico Tallarico; Mitchell L Shiffman; Silke Ahlers; Georgios Bakalos; Tarek Hassanein
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

4.  Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus.

Authors:  Nikolien van de Ven; Joe Fortunak; Bryony Simmons; Nathan Ford; Graham S Cooke; Saye Khoo; Andrew Hill
Journal:  Hepatology       Date:  2015-02-09       Impact factor: 17.425

5.  Replication priority of hepatitis C virus genotype 2a in a Chinese cohort.

Authors:  Zhen Yang; Yongxin Yu; Hongzhong Zhang; Guifang Shang; Jialiang Gao; Jian-Dong Jiang; Zonggen Peng
Journal:  Acta Pharm Sin B       Date:  2014-07-14       Impact factor: 11.413

6.  Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.

Authors:  Camila Fernanda da Silveira Alves; Camila Schultz Grott; Vagner Ricardo Lunge; Jorge Umberto Béria; Daniela Cardoso Tietzmann; Airton Tetelbom Stein; Daniel Simon
Journal:  Genet Mol Biol       Date:  2016-07-25       Impact factor: 1.771
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.